Spero Therapeutics Inc.

NASDAQ: SPRO · Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.90%
After-hours: Aug 15, 2025, 06:03 PM EDT

Spero Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
52.89M 76.33M 109.11M 112.58M
Short-Term Investments
n/a n/a n/a 33.82M
Long-Term Investments
n/a 46.59M n/a n/a
Other Long-Term Assets
153K 435K 10.2M 5.64M
Receivables
52.48M 50.7M 1.08M 2.64M
Inventory
n/a n/a -4.46M n/a
Other Current Assets
1.91M n/a 3.38M n/a
Total Current Assets
107.28M 131.21M 109.11M 157.87M
Property-Plant & Equipment
3.11M 4.16M 5.49M 7.56M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.27M 51.18M 15.7M 13.2M
Total Assets
110.54M 182.39M 124.8M 171.07M
Account Payables
7.31M 1.38M 617K 1.1M
Deferred Revenue
22.12M 27.11M 10.37M 1.86M
Short-Term Debt
n/a 1.72M 1.69M 1.36M
Other Current Liabilities
n/a 1.5M -1.24M 7.1M
Total Current Liabilities
49.07M 37.15M 21.65M 18.67M
Long-Term Debt
n/a n/a n/a 48.41M
Other Long-Term Liabilities
576K 23.69M 96K 940K
Total Long-Term Liabilities
15.35M 38.34M 27.22M 64.11M
Total Liabilities
64.42M 75.5M 48.87M 82.78M
Total Debt
4.3M 5.54M 6.65M 55.75M
Common Stock
55K 53K 52K 32K
Retained Earnings
-459.64M -391.07M -413.88M -367.46M
Comprehensive Income
n/a n/a n/a -2K
Shareholders Equity
46.12M 106.89M 75.93M 88.29M
Total Investments
n/a 46.59M n/a 33.82M